- Rizzolatti is recognized for his studies on autism, has been awarded the prestigious Prince of Asturias Award and is a candidate for the Nobel Prize.
- The Ever3 laboratory that is inaugurated will develop advanced biomedical research projects in cancer, mental disorders and cystic fibrosis with the financial support of the companies Negocenter, Concafé, Grupo Inverbur, Iberext, Larrión Grupo Empresarial, Club CEO España, Healthy Minds Analytics and Thera4All.
Next Tuesday, September 26, at 12 noon, Prof. Rizzolatti will go to the Ever3 laboratory where he will inaugurate the facilities that will bear his name, in recognition of his extensive career.
The company Ever3, which is part of the #SomosFPCM family, has been selected in the CaTaPull program of the Madrid City Council. Its innovations integrate the latest advances in neuroscience and artificial intelligence to detect and analyse the variables that determine the loss and retention of talent in companies in an effective, fast and reliable way, providing predictions with its own platform, useful for improving decision-making processes.
